Please select the option that best describes you:
Topics:
Breast Cancer • Radiation Oncology
Do you ever consider treating the axilla in patients with multiple nodes with ITCs?
Does the axilla have to be addressed surgically or with RT, given that the AMAROS trial eligibility criteria were amended to address sentinel lymph nodes with only ITC to be node negative, along with the results of IBCSG 23-01? Does it change if the patient is triple negative?
Answer from: Radiation Oncologist at Community Practice
ITC is treated like node negative and we do not address either by surgery or radiation for these early stage breast cancer treated by mastectomy.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
Agree with above. IHC is considered node negative by definition. No further axillary treatment is required.